1. Home
  2. GOSS vs ETJ Comparison

GOSS vs ETJ Comparison

Compare GOSS & ETJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.42

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

ETJ

Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.76

Market Cap

586.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOSS
ETJ
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
586.2M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
GOSS
ETJ
Price
$0.42
$8.76
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$8.83
N/A
AVG Volume (30 Days)
16.9M
157.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
78.81
N/A
EPS
N/A
N/A
Revenue
$114,701,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$7.70
52 Week High
$3.87
$9.12

Technical Indicators

Market Signals
Indicator
GOSS
ETJ
Relative Strength Index (RSI) 13.82 44.25
Support Level N/A $8.67
Resistance Level $1.31 $8.98
Average True Range (ATR) 0.17 0.08
MACD -0.18 -0.01
Stochastic Oscillator 1.65 38.46

Price Performance

Historical Comparison
GOSS
ETJ

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

Share on Social Networks: